Abstract Details

Title Analysis of Predictive Biomarkers for Estimation of MS Patients' Long-Term IFN-[beta] Therapy Outcome

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 001

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Brigitte Paap (University of Rostock)	No disclosure on file
Ronald M. Lazar, PhD, FAHA, FAAN, FAAN (University of Alabama At Birmingham)	Dr. Lazar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DiaMedica Therapeutics Inc. . The institution of Dr. Lazar has received research support from National Institutes of Health. Dr. Lazar has received publishing royalties from a publication relating to health care.
Michael Hecker, PhD (Universitatsmedizin Rostock, Klinik Fur Neurologie)	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file

��ɫ����